Authors

Sajeel Chowdhary, Boca Raton Regional Hospital; Eugene M. & Christine E. Lynn Cancer Institute; Marcus Neuroscience Institute; BocaCare? Physician NetworkFollow

Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial

Publication Date

6-2-2023

Content Type

Article

PubMed ID:

36640127

Additional Authors:

Additional authors and institutional affiliations

Citation

Sampson, J. H., Singh Achrol, A., Aghi, M. K., Bankiewicz, K., Bexon, M., Brem, S., Brenner, A., Chandhasin, C., Chowdhary, S., Coello, M., Ellingson, B. M., Floyd, J. R., Han, S., Kesari, S., Mardor, Y., Merchant, F., Merchant, N., Randazzo, D., Vogelbaum, M., Vrionis, F., … Butowski, N. (2023). Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial. Neuro-oncology, 25(6), 1085–1097. https://doi.org/10.1093/neuonc/noac285